FreeObituary Lisa Schwartz, expert in overtreatment and pathbreaking educator, dies at 55 December 07, 2018Vol.44 No.45By Barry Kramer
FreeGuest Editorial Reasons for hope for acute myeloid leukemia patients November 30, 2018Vol.44 No.44By Gwen Nichols
Drugs & TargetsFree Ziopharm Oncology announces Immuno-oncology Clinical Supply Agreement with Regeneron to evaluate combination therapy for brain cancer November 16, 2018Vol.44 No.43
Drugs & TargetsFree Immunomedics expands clinical collaboration with AstraZeneca to include metastatic NSCLC November 16, 2018Vol.44 No.43
Drugs & TargetsFree FDA grants priority review for Tecentriq + Abraxane for metastatic triple-negative breast cancer November 16, 2018Vol.44 No.43
Drugs & TargetsFree CHMP gives positive opinion for Kisqali combination therapy for all women with HR+/HER2- locally advanced or metastatic breast cancer November 16, 2018Vol.44 No.43
Drugs & TargetsFree FDA accepts novel clinical trial endpoint in approving Erleada for prostate cancer November 16, 2018Vol.44 No.43
Drugs & TargetsFree Using review pilot program, FDA takes two weeks to approve first-line treatment for peripheral T-cell lymphoma November 16, 2018Vol.44 No.43
Clinical RoundupFree Biodesix test predicts response to atezolizumab in lung cancer November 16, 2018Vol.44 No.43
Clinical RoundupFree Cardiovascular toxicities seen early in treatment with immune checkpoint inhibitors November 16, 2018Vol.44 No.43
